These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8423451)

  • 1. Characterization of African horsesickness virus serotype 4-induced polypeptides in Vero cells and their reactivity in Western immunoblotting.
    Laviada MD; Arias M; Sánchez-Vizcaíno JM
    J Gen Virol; 1993 Jan; 74 ( Pt 1)():81-7. PubMed ID: 8423451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and characterization of the two outer capsid proteins of African horsesickness virus: the role of VP2 in virus neutralization.
    Martinez-Torrecuadrada JL; Iwata H; Venteo A; Casal I; Roy P
    Virology; 1994 Jul; 202(1):348-59. PubMed ID: 8009847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Full protection against African horsesickness (AHS) in horses induced by baculovirus-derived AHS virus serotype 4 VP2, VP5 and VP7.
    Martínez-Torrecuadrada JL; Díaz-Laviada M; Roy P; Sánchez C; Vela C; Sánchez-Vizcaíno JM; Casal JI
    J Gen Virol; 1996 Jun; 77 ( Pt 6)():1211-21. PubMed ID: 8683209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of recombinant African horse sickness virus VP7 antigen via a simple method and validation of a VP7-based indirect ELISA for the detection of group-specific IgG antibodies in horse sera.
    Maree S; Paweska JT
    J Virol Methods; 2005 Apr; 125(1):55-65. PubMed ID: 15737417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic methods for African horsesickness virus using monoclonal antibodies to structural and non-structural proteins.
    Ranz AI; Miguet JG; Anaya C; Venteo A; Cortés E; Vela C; Sanz A
    Vet Microbiol; 1992 Nov; 33(1-4):143-53. PubMed ID: 1481354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Western immunoblotting as a method for the detection of African horse sickness virus protein-specific antibodies: differentiation between infected and vaccinated horses.
    Bougrine SI; Fihri OF; Fehri MM
    Arch Virol Suppl; 1998; 14():329-36. PubMed ID: 9785518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serologic markers in early stages of African horse sickness virus infection.
    Martínez-Torrecuadrada JL; Díaz-Laviada M; Roy P; Sánchez C; Vela C; Sánchez-Vizcaíno JM; Casal JI
    J Clin Microbiol; 1997 Feb; 35(2):531-5. PubMed ID: 9003637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant baculovirus-synthesized African horsesickness virus (AHSV) outer-capsid protein VP2 provides protection against virulent AHSV challenge.
    Roy P; Bishop DH; Howard S; Aitchison H; Erasmus B
    J Gen Virol; 1996 Sep; 77 ( Pt 9)():2053-7. PubMed ID: 8811002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a Microsphere-based Immunoassay for Serological Detection of African Horse Sickness Virus and Comparison with Other Diagnostic Techniques.
    Sánchez-Matamoros A; Beck C; Kukielka D; Lecollinet S; Blaise-Boisseau S; Garnier A; Rueda P; Zientara S; Sánchez-Vizcaíno JM
    Transbound Emerg Dis; 2016 Dec; 63(6):e270-e277. PubMed ID: 25693720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. African horse sickness virus structure.
    Roy P; Mertens PP; Casal I
    Comp Immunol Microbiol Infect Dis; 1994; 17(3-4):243-73. PubMed ID: 8001348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of African horsesickness virus and discrimination between two equine orbivirus serogroups by reverse transcription polymerase chain reaction.
    Bremer CW; Viljoen GJ
    Onderstepoort J Vet Res; 1998 Mar; 65(1):1-8. PubMed ID: 9629584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the major core antigen VP7 of African horsesickness virus by a recombinant baculovirus and its use as a group-specific diagnostic reagent.
    Chuma T; Le Blois H; Sánchez-Vizcaíno JM; Diaz-Laviada M; Roy P
    J Gen Virol; 1992 Apr; 73 ( Pt 4)():925-31. PubMed ID: 1378881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. African horsesickness virus VP7 sub-unit vaccine protects mice against a lethal, heterologous serotype challenge.
    Wade-Evans AM; Pullen L; Hamblin C; O'Hara R; Burroughs JN; Mertens PP
    J Gen Virol; 1997 Jul; 78 ( Pt 7)():1611-6. PubMed ID: 9225037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular production of African horsesickness virus core-like particles by expression of the two major core proteins, VP3 and VP7, in insect cells.
    Maree S; Durbach S; Huismans H
    J Gen Virol; 1998 Feb; 79 ( Pt 2)():333-7. PubMed ID: 9472617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and properties of virus particles, infectious subviral particles, cores and VP7 crystals of African horsesickness virus serotype 9.
    Burroughs JN; O'Hara RS; Smale CJ; Hamblin C; Walton A; Armstrong R; Mertens PP
    J Gen Virol; 1994 Aug; 75 ( Pt 8)():1849-57. PubMed ID: 8046387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of probes for typing African horsesickness virus isolates using a complete set of cloned VP2-genes.
    Koekemoer JJ; Potgieter AC; Paweska JT; Van Dijk AA
    J Virol Methods; 2000 Aug; 88(2):135-44. PubMed ID: 10960701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus.
    Guthrie AJ; Quan M; Lourens CW; Audonnet JC; Minke JM; Yao J; He L; Nordgren R; Gardner IA; Maclachlan NJ
    Vaccine; 2009 Jul; 27(33):4434-8. PubMed ID: 19490959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assembly of Replication-Incompetent African Horse Sickness Virus Particles: Rational Design of Vaccines for All Serotypes.
    Lulla V; Lulla A; Wernike K; Aebischer A; Beer M; Roy P
    J Virol; 2016 Aug; 90(16):7405-7414. PubMed ID: 27279609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural insight into African horsesickness virus infection.
    Manole V; Laurinmäki P; Van Wyngaardt W; Potgieter CA; Wright IM; Venter GJ; van Dijk AA; Sewell BT; Butcher SJ
    J Virol; 2012 Aug; 86(15):7858-66. PubMed ID: 22593166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with VP2 is sufficient for protection against lethal challenge with African horsesickness virus Type 4.
    Stone-Marschat MA; Moss SR; Burrage TG; Barber ML; Roy P; Laegreid WW
    Virology; 1996 Jun; 220(1):219-22. PubMed ID: 8659117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.